Moxetumomab Pasudotox-tdfk (Lumoxiti ™) is a CD-22 directed cytotoxin used in the treatment of some cases of hairy cell leukemia.
What's New
There are a number of genetic disorders that are seen more commonly in the Ashkenazi population, several with links to cancer risk.
Iobenguane I-131 (Azedra®) is a radiopharmaceutical medication used in the treatment of iobenguane scan positive pheochromocytoma and paraganglioma in individuals 12 years or older .
Mogamulizumab-kpkc is a CC chemokine receptor type 4 directed monoclonal antibody used in the treatment of Sezary syndrome and mycosis fungoides.
OncoLink Apps
Blogs
OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
View all Blogs
September's Awareness Months
Many types of cancer are recognized during the month of September including childhood, gynecologic, prostate, and thyroid cancers, leukemia, and lymphoma. OncoLink offers up-to-date articles about these cancers, their treatment, and support resources.
Need Cancer Patient Education Tools?
Our award winning cancer education content is now available for licensing and syndication.
I Wish U Knew!
I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.